FDA Adverse Event
Injury
Summary report: N
DIASORIN LIASON XL HSV 1 TYPE SPECIFIC ANTIBODY TEST
MDR report key: 16643549
·
Received March 29, 2023
Report
- Report Number
- MW5116080
- Event Type
- Injury
- Date Received
- March 29, 2023
- Date of Event
- June 15, 2022
- Report Date
- March 27, 2023
- Manufacturer
- DIASORIN, INC.
- Product Code
- MXJ
- Adverse Event
- Yes
- Product Problem
- Yes
- Report Source
- Voluntary report
- Reporter Location
- OR, US
- Reporter Occupation
- 117
- Health Professional
- Yes
Narratives
Description of Event or Problem · 0
PATIENT HAD A POSITIVE HSV 1 AND 2 TEST ON THE DIASORIN HSV 1 AND 2 IGG TEST, FOLLOWED UP WITH THE WESTERN BLOT WHICH WAS NEGATIVE FOR HSV 1 AND 2. DATE GIVEN IS THE WESTERN BLOT CONFIRMATORY TEST. REFERENCE REPORT: MW5116081.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 391883 | DIASORIN LIASON XL HSV 1 TYPE SPECIFIC ANTIBODY TEST | ENZYME LINKED IMMUNOSORBENT ASSAY, HERPES SIMPLEX VIRUS, HSV-1 | MXJ | DIASORIN, INC. |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 29 YR | Male | Other |